Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

SCAG vs XPEV

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SCAG
Scage Future American Depositary Shares

Manufacturing - Tools & Accessories

IndustrialsNASDAQ • US
Market Cap$6M
5Y Perf.-90.7%
XPEV
XPeng Inc.

Auto - Manufacturers

Consumer CyclicalNYSE • CN
Market Cap$5.42B
5Y Perf.-13.0%

SCAG vs XPEV — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SCAG logoSCAG
XPEV logoXPEV
IndustryManufacturing - Tools & AccessoriesAuto - Manufacturers
Market Cap$6M$5.42B
Revenue (TTM)$0.00$60.29B
Net Income (TTM)$-215K$-4.28B
Gross Margin15.7%
Operating Margin-8.9%
Total Debt$3M$15.94B
Cash & Equiv.$769.00$18.59B

SCAG vs XPEVLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SCAG
XPEV
StockJun 25May 26Return
Scage Future Americ… (SCAG)1009.3-90.7%
XPeng Inc. (XPEV)10087.0-13.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: SCAG vs XPEV

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: XPEV leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Scage Future American Depositary Shares is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SCAG
Scage Future American Depositary Shares
The Quality Compounder

SCAG is the clearest fit if your priority is quality and efficiency.

  • 13.7% margin vs XPEV's -7.1%
  • -2.1% ROA vs XPEV's -5.0%
Best for: quality and efficiency
XPEV
XPeng Inc.
The Income Pick

XPEV carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 1.39
  • Rev growth 33.2%, EPS growth 48.7%, 3Y rev CAGR 24.9%
  • -26.7% 10Y total return vs SCAG's -94.4%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthXPEV logoXPEV33.2% revenue growth vs SCAG's -100.0%
Quality / MarginsSCAG logoSCAG13.7% margin vs XPEV's -7.1%
Stability / SafetyXPEV logoXPEVBeta 1.39 vs SCAG's 1.42, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)XPEV logoXPEV-18.9% vs SCAG's -94.4%
Efficiency (ROA)SCAG logoSCAG-2.1% ROA vs XPEV's -5.0%

SCAG vs XPEV — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SCAGScage Future American Depositary Shares

Segment breakdown not available.

XPEVXPeng Inc.
FY 2024
Vehicle
87.7%$35.8B
Service, Other
12.3%$5.0B

SCAG vs XPEV — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLXPEVLAGGINGSCAG

Income & Cash Flow (Last 12 Months)

Insufficient data to determine a leader in this category.

XPEV and SCAG operate at a comparable scale, with $60.3B and $0 in trailing revenue.

MetricSCAG logoSCAGScage Future Amer…XPEV logoXPEVXPeng Inc.
RevenueTrailing 12 months$0$60.3B
EBITDAEarnings before interest/tax-$215,486-$3.9B
Net IncomeAfter-tax profit-$215,486-$4.3B
Free Cash FlowCash after capex-$877,920$0
Gross MarginGross profit ÷ Revenue+15.7%
Operating MarginEBIT ÷ Revenue-8.9%
Net MarginNet income ÷ Revenue-7.1%
FCF MarginFCF ÷ Revenue-10.9%
Rev. Growth (YoY)Latest quarter vs prior year+125.3%
EPS Growth (YoY)Latest quarter vs prior year+63.2%
Insufficient data to determine a leader in this category.

Valuation Metrics

SCAG leads this category, winning 2 of 2 comparable metrics.
MetricSCAG logoSCAGScage Future Amer…XPEV logoXPEVXPeng Inc.
Market CapShares × price$6M$5.4B
Enterprise ValueMkt cap + debt − cash$9M$5.0B
Trailing P/EPrice ÷ TTM EPS-28.18x-17.29x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue0.90x
Price / BookPrice ÷ Book value/share1.19x3.20x
Price / FCFMarket cap ÷ FCF
SCAG leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

XPEV leads this category, winning 4 of 7 comparable metrics.

SCAG delivers a -4.2% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-14 for XPEV. XPEV carries lower financial leverage with a 0.51x debt-to-equity ratio, signaling a more conservative balance sheet compared to SCAG's 0.56x. On the Piotroski fundamental quality scale (0–9), XPEV scores 4/9 vs SCAG's 3/9, reflecting mixed financial health.

MetricSCAG logoSCAGScage Future Amer…XPEV logoXPEVXPeng Inc.
ROE (TTM)Return on equity-4.2%-13.8%
ROA (TTM)Return on assets-2.1%-5.0%
ROICReturn on invested capital-16.9%
ROCEReturn on capital employed-108.3%-14.7%
Piotroski ScoreFundamental quality 0–934
Debt / EquityFinancial leverage0.56x0.51x
Net DebtTotal debt minus cash$3M-$2.6B
Cash & Equiv.Liquid assets$769$18.6B
Total DebtShort + long-term debt$3M$15.9B
Interest CoverageEBIT ÷ Interest expense-10.29x
XPEV leads this category, winning 4 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

XPEV leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in XPEV five years ago would be worth $5,826 today (with dividends reinvested), compared to $556 for SCAG. Over the past 12 months, XPEV leads with a -18.9% total return vs SCAG's -94.4%. The 3-year compound annual growth rate (CAGR) favors XPEV at 13.8% vs SCAG's -61.8% — a key indicator of consistent wealth creation.

MetricSCAG logoSCAGScage Future Amer…XPEV logoXPEVXPeng Inc.
YTD ReturnYear-to-date-58.7%-23.9%
1-Year ReturnPast 12 months-94.4%-18.9%
3-Year ReturnCumulative with dividends-94.4%+47.4%
5-Year ReturnCumulative with dividends-94.4%-41.7%
10-Year ReturnCumulative with dividends-94.4%-26.7%
CAGR (3Y)Annualised 3-year return-61.8%+13.8%
XPEV leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

XPEV leads this category, winning 2 of 2 comparable metrics.

XPEV is the less volatile stock with a 1.39 beta — it tends to amplify market swings less than SCAG's 1.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. XPEV currently trades 55.1% from its 52-week high vs SCAG's 3.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSCAG logoSCAGScage Future Amer…XPEV logoXPEVXPeng Inc.
Beta (5Y)Sensitivity to S&P 5001.42x1.39x
52-Week HighHighest price in past year$24.47$28.24
52-Week LowLowest price in past year$0.80$15.38
% of 52W HighCurrent price vs 52-week peak+3.4%+55.1%
RSI (14)Momentum oscillator 0–10032.240.2
Avg Volume (50D)Average daily shares traded9K6.4M
XPEV leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricSCAG logoSCAGScage Future Amer…XPEV logoXPEVXPeng Inc.
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$25.50
# AnalystsCovering analysts17
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+100.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

XPEV leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). SCAG leads in 1 (Valuation Metrics).

Best OverallXPeng Inc. (XPEV)Leads 3 of 6 categories
Loading custom metrics...

SCAG vs XPEV: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is SCAG or XPEV a better buy right now?

For growth investors, XPeng Inc.

(XPEV) is the stronger pick with 33. 2% revenue growth year-over-year, versus -100. 0% for Scage Future American Depositary Shares (SCAG). Analysts rate XPeng Inc. (XPEV) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SCAG or XPEV?

Over the past 5 years, XPeng Inc.

(XPEV) delivered a total return of -41. 7%, compared to -94. 4% for Scage Future American Depositary Shares (SCAG). Over 10 years, the gap is even starker: XPEV returned -26. 7% versus SCAG's -94. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SCAG or XPEV?

By beta (market sensitivity over 5 years), XPeng Inc.

(XPEV) is the lower-risk stock at 1. 39β versus Scage Future American Depositary Shares's 1. 42β — meaning SCAG is approximately 2% more volatile than XPEV relative to the S&P 500. On balance sheet safety, XPeng Inc. (XPEV) carries a lower debt/equity ratio of 51% versus 56% for Scage Future American Depositary Shares — giving it more financial flexibility in a downturn.

04

Which is growing faster — SCAG or XPEV?

By revenue growth (latest reported year), XPeng Inc.

(XPEV) is pulling ahead at 33. 2% versus -100. 0% for Scage Future American Depositary Shares (SCAG). On earnings-per-share growth, the picture is similar: Scage Future American Depositary Shares grew EPS 73. 1% year-over-year, compared to 48. 7% for XPeng Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SCAG or XPEV?

Scage Future American Depositary Shares (SCAG) is the more profitable company, earning 0.

0% net margin versus -14. 2% for XPeng Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SCAG leads at 0. 0% versus -16. 3% for XPEV. At the gross margin level — before operating expenses — XPEV leads at 14. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SCAG or XPEV?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is SCAG or XPEV better for a retirement portfolio?

For long-horizon retirement investors, XPeng Inc.

(XPEV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Both have compounded well over 10 years (XPEV: -26. 7%, SCAG: -94. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SCAG and XPEV?

These companies operate in different sectors (SCAG (Industrials) and XPEV (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SCAG is a small-cap quality compounder stock; XPEV is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

SCAG

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
Run This Screen
Stocks Like

XPEV

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 62%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SCAG and XPEV on the metrics below

Revenue Growth>
%
(SCAG: -100.0% · XPEV: 125.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.